Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves Β· freshest Wall Street data, updated daily View live feed β†’
Analyst Tracker/Ivan Bokhmat
BARC

Ivan Bokhmat

Wall Street Analyst
β˜…β˜…β˜…β˜…β˜†
#754
on 13Foresight Β· ranked by our own returns
62%
Success Rate
+1.3%
Average Return
32 of 52 calls profitable Β· +13.9% vs benchmark
S&P 500 (SPY)
πŸ“ˆ Across the calls we could measure, roughly 62% of Ivan Bokhmat's ratings turned a profit when each position was held for 2 year β€” averaging +1.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

38 Buy 24 Hold 28 Sell
Ivan's Stock Coverage 18 ratings Β· 2026-11-16
Company Date Position Consensus β“˜ Price Target β“˜ 2-Yr Return vs S&P 500 β“˜
GB:PRU
Prudential
Oct 30, 2026 BUY Strong Buy
+812.3% avg upside
24 analysts
$1400.00
51.91% Upside
+0.1% Β·
GB:CRE
Conduit Holdings Ltd
Oct 23, 2026 SELL Buy
+16.6% avg upside
6 analysts
$430.00
2.01% Downside
+1.3% Β·
CH:SREN
Swiss Re AG
Oct 23, 2026 SELL Sell
-20.7% avg upside
15 analysts
$124.00
19.24% Downside
+1.3% Β·
GB:HSX
Hiscox
Oct 23, 2026 BUY Strong Buy
+272.7% avg upside
15 analysts
$2070.00
10.20% Upside
+4.2% Β·
GB:AV
Aviva plc
Oct 23, 2026 HOLD Buy
-7.6% avg upside
17 analysts
$721.00
1.84% Downside
+2.6% Β·
DE:MUV2
Munich Reinsurance
Oct 23, 2026 BUY Buy
-15.5% avg upside
17 analysts
$594.00
4.80% Upside
+2.1% Β·
GB:LRE
Lancashire Holdings
Oct 23, 2026 SELL Hold
+480.2% avg upside
12 analysts
$530.00
22.78% Downside
-1.3% Β·
GB:SBRE
Sabre Insurance Group plc
Oct 21, 2026 BUY Buy
+8.4% avg upside
7 analysts
$193.00
11.99% Upside
+4.2% Β·
FR:SCR
SCOR
Oct 12, 2026 HOLD Buy
-3.0% avg upside
12 analysts
$32.30
6.48% Downside
+4.4% Β·
GB:ADM
Admiral
Sep 03, 2026 BUY Buy
-9.1% avg upside
14 analysts
$4083.00
5.33% Upside
+3.1% Β·
DE:HNR1
Hannover Rueck
May 26, 2026 SELL Buy
-7.7% avg upside
16 analysts
$246.00
15.17% Downside
-22.0% Β·
ES:MAP
Mapfre, SA
Apr 11, 2023 SELL Sell
-21.4% avg upside
4 analysts
$1.75
56.12% Downside
-64.4% Β·
DE:ALV
Allianz
Jun 30, 2022 HOLD Buy
-13.3% avg upside
23 analysts
β€” +60.2% Β·
CH:ZURN
Zurich Insurance Group
Jun 30, 2022 BUY Hold
-3.7% avg upside
16 analysts
β€” +28.5% Β·
FR:CS
AXA SA
Jun 30, 2022 BUY Strong Buy
+8.8% avg upside
19 analysts
β€” +62.3% Β·
IT:G
Assicurazioni Generali S.p.A.
Jun 30, 2022 SELL Hold
-10.4% avg upside
16 analysts
β€” -72.6% Β·
NL:NN
NN Group N.V.
Feb 18, 2019 SELL Buy
-12.3% avg upside
13 analysts
$110.50
42.05% Upside
-9.7% Β·
SSREY
Swiss Re
Dec 13, 2018 BUY Strong Buy
+177.7% avg upside
4 analysts
$123.91
166.79% Upside
+14.7% Β·
πŸ”’ 13 more ratings β€” with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Ivan Bokhmat β€” Frequently Asked Questions
How accurate are Ivan Bokhmat's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Ivan's ratings were profitable over a one-year hold, with an average return of +1.6% per rating, or -2.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Ivan ranked on 13Foresight?
Ivan Bokhmat is currently ranked #754 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge β€” so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ivan cover?
Ivan most recently has ratings on GB:PRU, GB:CRE, CH:SREN, GB:HSX, GB:AV, DE:MUV2, GB:LRE, GB:SBRE, FR:SCR, GB:ADM, DE:HNR1, ES:MAP and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.